Meta Health Limited provided consolidated financial guidance for the first half year ended June 30, 2022. For the period, the company expects to report a net loss. The net loss for HY2022 was mainly due to a decrease in sales revenue resulting from (i) lockdown in Shanghai for close to two months due to the COVID-19 pandemic that severely impacted the sales in China, (ii) shortage of IC chips that affected the Group's customers' demands, and (iii) uncertainty in Europe caused by the war in Ukraine and the on-going Sino-US trade war.